Smith Plus Nephew
Smith & Nephew, a leading global medical technology company, is headquartered in the United Kingdom. Founded in 1856, the company has established itself as a key player in the orthopaedics, advanced wound management, and sports medicine sectors. With a strong presence in Europe, North America, and Asia-Pacific, Smith & Nephew is renowned for its innovative products, including advanced wound dressings and joint reconstruction solutions. The company’s commitment to research and development has led to significant milestones, such as the introduction of pioneering surgical instruments and biologics. Smith & Nephew's unique offerings, like the PICO™ negative pressure wound therapy system, set it apart in the competitive landscape. Recognised for its quality and reliability, Smith & Nephew continues to enhance patient outcomes and maintain a strong market position in the medical technology industry.
DitchCarbon Score
How does Smith Plus Nephew's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Smith Plus Nephew's score of 43 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Smith Plus Nephew's reported carbon emissions
In 2023, Smith & Nephew reported global carbon emissions of approximately 40,266,000 kg CO2e, comprising 15,901,000 kg CO2e from Scope 1 and 24,365,000 kg CO2e from Scope 2 emissions. The company also reported significant Scope 3 emissions, estimated at about 1,300,000,000 kg CO2e. Smith & Nephew has set ambitious climate commitments, aiming for net zero emissions for Scope 1 and Scope 2 by 2040, and for Scope 3 by 2045. To achieve this, they plan to reduce Scope 1 and Scope 2 emissions by 70% by 2025. This commitment reflects their dedication to sustainability and aligns with industry standards for climate action. Overall, Smith & Nephew's proactive approach to reducing carbon emissions positions them as a leader in environmental responsibility within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2002 | 2003 | 2004 | 2005 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 47,888,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 15,090,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,021,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Smith Plus Nephew is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
